Millennium Management’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-8,231
| Closed | -$53K | – | 4504 |
|
2022
Q4 | $53K | Buy |
8,231
+2,164
| +36% | +$13.9K | ﹤0.01% | 4437 |
|
2022
Q3 | $79K | Buy |
6,067
+5,554
| +1,083% | +$72.3K | ﹤0.01% | 4752 |
|
2022
Q2 | $8K | Buy |
+513
| New | +$8K | ﹤0.01% | 5011 |
|
2021
Q3 | – | Sell |
-1,660
| Closed | -$162K | – | 5086 |
|
2021
Q2 | $162K | Buy |
+1,660
| New | +$162K | ﹤0.01% | 4758 |
|
2021
Q1 | – | Sell |
-4,811
| Closed | -$473K | – | 4446 |
|
2020
Q4 | $473K | Buy |
4,811
+3,803
| +377% | +$374K | ﹤0.01% | 3274 |
|
2020
Q3 | $485 | Sell |
1,008
-8
| -0.8% | -$4 | ﹤0.01% | 2858 |
|
2020
Q2 | $788K | Buy |
+1,016
| New | +$788K | ﹤0.01% | 2507 |
|
2020
Q1 | – | Sell |
-317
| Closed | -$291K | – | 3122 |
|
2019
Q4 | $291K | Buy |
+317
| New | +$291K | ﹤0.01% | 2993 |
|